| 1 |
34373746 | Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers. | 2021 |
1 |
| 2 |
32711417 | ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy. | 2020 Jul 1 |
1 |
| 3 |
32880833 | Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh. | 2020 Sep |
3 |
| 4 |
33150172 | Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis. | 2020 |
5 |
| 5 |
29662106 | Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients. | 2019 Apr |
1 |
| 6 |
31602266 | Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. | 2019 |
1 |
| 7 |
29491212 | Association of DNA Repair and Drug Transporter in Relation to Chemosensitivity in Primary Culture of Thai Gastric Cancer Patients. | 2018 |
2 |
| 8 |
30407287 | XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy: A systematic review and MOOSE-compliant meta-analysis. | 2018 Nov |
1 |
| 9 |
28332164 | Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy. | 2017 Apr |
1 |
| 10 |
28520216 | Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis. | 2017 Dec |
1 |
| 11 |
28608017 | Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy. | 2017 Nov |
2 |
| 12 |
28743242 | Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement. | 2017 Jul 25 |
4 |
| 13 |
27248474 | Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis. | 2016 Aug 23 |
2 |
| 14 |
27478321 | Prognostic significance of X-ray cross-complementing gene 1 expression in gastric cancer. | 2016 Jun |
4 |
| 15 |
25784983 | XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects. | 2015 |
4 |
| 16 |
26458583 | Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer. | 2015 Jul-Sep |
5 |
| 17 |
26585370 | Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy. | 2015 Nov 20 |
2 |
| 18 |
24224851 | X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis. | 2014 May |
5 |
| 19 |
24446315 | Pharmacogenetics of DNA repair gene polymorphisms in non-small-cell lung carcinoma patients on platinum-based chemotherapy. | 2014 Jan 14 |
1 |
| 20 |
24465544 | Association between polymorphisms in XRCC1 gene and treatment outcomes of patients with advanced gastric cancer: a systematic review and meta-analysis. | 2014 |
1 |
| 21 |
24525731 | TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. | 2014 Feb 13 |
2 |
| 22 |
24634242 | Pharmacogenetic role of XRCC1 polymorphisms on the clinical outcome of gastric cancer patients with platinum-based chemotherapy: a systematic review and meta-analysis. | 2014 Mar 6 |
3 |
| 23 |
24729390 | Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients. | 2014 Dec 1 |
1 |
| 24 |
24737519 | Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer. | 2014 Mar 31 |
3 |
| 25 |
24938464 | Polymorphisms in the XRCC1 gene are associated with treatment response to platinum chemotherapy in advanced non-small cell lung cancer patients based on meta-analysis. | 2014 May 16 |
6 |
| 26 |
25476899 | JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. | 2014 Dec 4 |
1 |
| 27 |
22821704 | Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. | 2013 Dec |
1 |
| 28 |
22983827 | Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population. | 2013 Jan |
2 |
| 29 |
23225521 | Clinicopathological and functional significance of XRCC1 expression in ovarian cancer. | 2013 Jun 15 |
1 |
| 30 |
23479135 | Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. | 2013 May |
2 |
| 31 |
21805378 | DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. | 2012 Sep |
2 |
| 32 |
22339849 | Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. | 2012 Feb 17 |
1 |
| 33 |
22452940 | Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. | 2012 May 15 |
1 |
| 34 |
22551904 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. | 2012 Jun |
3 |
| 35 |
22705987 | Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis. | 2012 Jul 15 |
3 |
| 36 |
22938418 | Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy. | 2012 |
1 |
| 37 |
22982660 | DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy. | 2012 Oct |
1 |
| 38 |
23125080 | XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. | 2012 Nov |
5 |
| 39 |
23167352 | Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. | 2012 |
2 |
| 40 |
23464469 | XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis. | 2012 |
3 |
| 41 |
21129812 | Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. | 2011 Jul |
2 |
| 42 |
22009704 | Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. | 2011 |
5 |
| 43 |
22152690 | [Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer]. | 2011 Dec |
4 |
| 44 |
20814250 | No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy. | 2010 Nov 1 |
2 |
| 45 |
19157633 | Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients. | 2009 Aug |
3 |
| 46 |
19563645 | The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. | 2009 Jun 29 |
1 |
| 47 |
20104979 | Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers. | 2009 |
1 |
| 48 |
20719167 | Gene Polymorphisms and Chemotherapy in Non-small Cell Lung Cancer. | 2009 Aug 20 |
1 |
| 49 |
18851872 | XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. | 2008 Dec |
1 |
| 50 |
16875604 | [XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer]. | 2006 Mar |
4 |